

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.07404482 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.07404482 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.95988699 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.91052676 |
| 5 | positive thymic T cell selection (GO:0045059) | 5.31251008 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.22572810 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.22035144 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.22035144 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.07109486 |
| 10 | detection of other organism (GO:0098543) | 4.87692406 |
| 11 | negative T cell selection (GO:0043383) | 4.75163680 |
| 12 | negative thymic T cell selection (GO:0045060) | 4.74931829 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.73680623 |
| 14 | detection of bacterium (GO:0016045) | 4.69899861 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.68397234 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.60636185 |
| 17 | response to peptidoglycan (GO:0032494) | 4.42460540 |
| 18 | leukocyte aggregation (GO:0070486) | 4.37331579 |
| 19 | thymic T cell selection (GO:0045061) | 4.37126274 |
| 20 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.32298660 |
| 21 | positive T cell selection (GO:0043368) | 4.25805630 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.13098637 |
| 23 | T cell migration (GO:0072678) | 4.03607427 |
| 24 | response to interleukin-15 (GO:0070672) | 4.01449755 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.98849678 |
| 26 | T cell selection (GO:0045058) | 3.93646244 |
| 27 | B cell receptor signaling pathway (GO:0050853) | 3.91395911 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 3.90851310 |
| 29 | cellular extravasation (GO:0045123) | 3.85754975 |
| 30 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.84388754 |
| 31 | regulation of T cell tolerance induction (GO:0002664) | 3.80279968 |
| 32 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.77694072 |
| 33 | negative regulation of T cell mediated immunity (GO:0002710) | 3.74202864 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.73660062 |
| 35 | response to host immune response (GO:0052572) | 3.73660062 |
| 36 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.71922447 |
| 37 | interferon-gamma production (GO:0032609) | 3.71422891 |
| 38 | tolerance induction (GO:0002507) | 3.71322825 |
| 39 | morphogenesis of an endothelium (GO:0003159) | 3.66028736 |
| 40 | endothelial tube morphogenesis (GO:0061154) | 3.66028736 |
| 41 | regulation of B cell differentiation (GO:0045577) | 3.64540323 |
| 42 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.63093966 |
| 43 | detection of biotic stimulus (GO:0009595) | 3.62210154 |
| 44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.61212008 |
| 45 | cellular response to interleukin-15 (GO:0071350) | 3.59998288 |
| 46 | microglial cell activation (GO:0001774) | 3.54603405 |
| 47 | type I interferon signaling pathway (GO:0060337) | 3.54279149 |
| 48 | cellular response to type I interferon (GO:0071357) | 3.54279149 |
| 49 | leukocyte cell-cell adhesion (GO:0007159) | 3.54186132 |
| 50 | response to host (GO:0075136) | 3.52704239 |
| 51 | response to host defenses (GO:0052200) | 3.52704239 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.52704239 |
| 53 | response to type I interferon (GO:0034340) | 3.52090405 |
| 54 | regulation of mast cell degranulation (GO:0043304) | 3.51726370 |
| 55 | myeloid cell activation involved in immune response (GO:0002275) | 3.50646277 |
| 56 | macrophage activation (GO:0042116) | 3.37695047 |
| 57 | neutrophil mediated immunity (GO:0002446) | 3.36148429 |
| 58 | positive regulation of tolerance induction (GO:0002645) | 3.35949278 |
| 59 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.35235479 |
| 60 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.30605217 |
| 61 | activated T cell proliferation (GO:0050798) | 3.30564041 |
| 62 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.27855636 |
| 63 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.27301028 |
| 64 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.21877735 |
| 65 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.20513061 |
| 66 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20387126 |
| 67 | negative regulation of phagocytosis (GO:0050765) | 3.20223985 |
| 68 | T cell costimulation (GO:0031295) | 3.19233217 |
| 69 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.18534330 |
| 70 | response to laminar fluid shear stress (GO:0034616) | 3.18472866 |
| 71 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.18389662 |
| 72 | positive regulation of B cell differentiation (GO:0045579) | 3.18329523 |
| 73 | regulation of leukocyte degranulation (GO:0043300) | 3.17474458 |
| 74 | defense response to protozoan (GO:0042832) | 3.17266420 |
| 75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.14949144 |
| 76 | positive regulation of isotype switching (GO:0045830) | 3.14185560 |
| 77 | leukocyte degranulation (GO:0043299) | 3.12867359 |
| 78 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.12692353 |
| 79 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.12611854 |
| 80 | lymphocyte costimulation (GO:0031294) | 3.11740699 |
| 81 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.09611976 |
| 82 | negative regulation of innate immune response (GO:0045824) | 3.06216514 |
| 83 | positive regulation of mast cell activation (GO:0033005) | 3.05484863 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.05111964 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.05042403 |
| 86 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.05042403 |
| 87 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.04244304 |
| 88 | positive regulation of histone deacetylation (GO:0031065) | 3.04039404 |
| 89 | regulation of tolerance induction (GO:0002643) | 3.03563526 |
| 90 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.00830215 |
| 91 | positive regulation of lamellipodium assembly (GO:0010592) | 2.99462257 |
| 92 | regulation of mast cell activation (GO:0033003) | 2.98925334 |
| 93 | heterotypic cell-cell adhesion (GO:0034113) | 2.98216977 |
| 94 | B cell mediated immunity (GO:0019724) | 2.97596498 |
| 95 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.97487075 |
| 96 | T cell receptor signaling pathway (GO:0050852) | 2.94826849 |
| 97 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.94108210 |
| 98 | negative regulation of interleukin-6 production (GO:0032715) | 2.92150357 |
| 99 | negative regulation of type 2 immune response (GO:0002829) | 2.91076604 |
| 100 | myeloid leukocyte mediated immunity (GO:0002444) | 2.90001501 |
| 101 | positive regulation of antigen processing and presentation (GO:0002579) | 2.89820595 |
| 102 | negative regulation of interleukin-12 production (GO:0032695) | 2.89378904 |
| 103 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.88741289 |
| 104 | endothelial cell chemotaxis (GO:0035767) | 2.87417809 |
| 105 | neutrophil activation (GO:0042119) | 2.80667240 |
| 106 | angiogenesis involved in wound healing (GO:0060055) | 2.78450171 |
| 107 | pinocytosis (GO:0006907) | 2.78008345 |
| 108 | establishment of endothelial barrier (GO:0061028) | 2.77837311 |
| 109 | regulation of response to interferon-gamma (GO:0060330) | 2.76327469 |
| 110 | negative regulation of granulocyte differentiation (GO:0030853) | 2.73917116 |
| 111 | positive regulation by symbiont of host defense response (GO:0052509) | 2.73421834 |
| 112 | modulation by symbiont of host defense response (GO:0052031) | 2.73421834 |
| 113 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.73421834 |
| 114 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.73421834 |
| 115 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.73421834 |
| 116 | modulation by symbiont of host immune response (GO:0052553) | 2.73421834 |
| 117 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.73090352 |
| 118 | T cell proliferation (GO:0042098) | 2.69172598 |
| 119 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.68083718 |
| 120 | immunoglobulin mediated immune response (GO:0016064) | 2.67794695 |
| 121 | negative regulation of stress fiber assembly (GO:0051497) | 2.67472267 |
| 122 | germinal center formation (GO:0002467) | 2.67170987 |
| 123 | neutrophil activation involved in immune response (GO:0002283) | 2.66593558 |
| 124 | cellular response to zinc ion (GO:0071294) | 2.66202894 |
| 125 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.65831948 |
| 126 | positive regulation of B cell mediated immunity (GO:0002714) | 2.65831948 |
| 127 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.65082336 |
| 128 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.64964988 |
| 129 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.64964988 |
| 130 | NIK/NF-kappaB signaling (GO:0038061) | 2.64449673 |
| 131 | mannose metabolic process (GO:0006013) | 2.63996071 |
| 132 | respiratory burst (GO:0045730) | 2.63764652 |
| 133 | positive regulation of interleukin-2 production (GO:0032743) | 2.63138764 |
| 134 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.62938800 |
| 135 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.60572901 |
| 136 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.59348917 |
| 137 | positive regulation of lamellipodium organization (GO:1902745) | 2.59171733 |
| 138 | leukocyte tethering or rolling (GO:0050901) | 2.57659658 |
| 139 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.56072968 |
| 140 | granulocyte activation (GO:0036230) | 2.55366119 |
| 141 | positive regulation of DNA recombination (GO:0045911) | 2.55307827 |
| 142 | natural killer cell activation (GO:0030101) | 2.55259855 |
| 143 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.54606725 |
| 144 | regulation of antigen processing and presentation (GO:0002577) | 2.54447335 |
| 145 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.54294467 |
| 146 | response to muramyl dipeptide (GO:0032495) | 2.54289305 |
| 147 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.54224190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.29929717 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.78621536 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.03962730 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.24502201 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.14000536 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.13336142 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.12648222 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.11920935 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.00236966 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.82010834 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.80136667 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.78951811 |
| 13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.75367973 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.71734248 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70091452 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.61191830 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.60344939 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.54855096 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.53813545 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48954983 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.48925901 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39908582 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.32397649 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.28477501 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.23072546 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.15966773 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14718602 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.13358197 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12556308 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.10263756 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.99837183 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.97744940 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.97023267 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95752500 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.90138830 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87410045 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.86622193 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83993043 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.83409011 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.82196768 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.81542066 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70422984 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.63777954 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.62722962 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.59008159 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58269937 |
| 47 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.53374403 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.53365998 |
| 49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.51125441 |
| 50 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49527747 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44715383 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44344287 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43838955 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.43465547 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40161789 |
| 56 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34473063 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34124068 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28328937 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28210977 |
| 60 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27263810 |
| 61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26795522 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25104865 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22746139 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22242383 |
| 65 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20880384 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20316706 |
| 67 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19965626 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19279578 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17618697 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16701056 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16486696 |
| 72 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16129620 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15570565 |
| 74 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15283276 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15161100 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13975251 |
| 77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13563653 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11640062 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09161285 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08668075 |
| 81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08642811 |
| 82 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08633587 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06909357 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05819530 |
| 85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04627246 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04452032 |
| 87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04080780 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03923489 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03282421 |
| 90 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03193499 |
| 91 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01714537 |
| 92 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00952900 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00508686 |
| 94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00464988 |
| 95 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.99598041 |
| 96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99288890 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97638035 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94906856 |
| 99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94656799 |
| 100 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94226140 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93736730 |
| 102 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92320717 |
| 103 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91989103 |
| 104 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91955277 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90086852 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87063997 |
| 107 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86231600 |
| 108 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86177400 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83234050 |
| 110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82872589 |
| 111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81945381 |
| 112 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.81907751 |
| 113 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.81831383 |
| 114 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81142683 |
| 115 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80793016 |
| 116 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.80668398 |
| 117 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80327091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.28261662 |
| 2 | MP0000685_abnormal_immune_system | 3.11067514 |
| 3 | MP0005387_immune_system_phenotype | 2.93071064 |
| 4 | MP0001790_abnormal_immune_system | 2.93071064 |
| 5 | MP0003303_peritoneal_inflammation | 2.88731293 |
| 6 | MP0001800_abnormal_humoral_immune | 2.79539623 |
| 7 | MP0005671_abnormal_response_to | 2.79012140 |
| 8 | MP0003436_decreased_susceptibility_to | 2.69721736 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.68814854 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.49019068 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.46900296 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.42178317 |
| 13 | MP0003724_increased_susceptibility_to | 2.36136268 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.34666077 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.32859336 |
| 16 | MP0001819_abnormal_immune_cell | 2.29790830 |
| 17 | MP0009785_altered_susceptibility_to | 2.29565803 |
| 18 | MP0002723_abnormal_immune_serum | 2.26169586 |
| 19 | MP0005025_abnormal_response_to | 2.25083129 |
| 20 | MP0002405_respiratory_system_inflammati | 2.12542436 |
| 21 | MP0002419_abnormal_innate_immunity | 2.11849957 |
| 22 | MP0002398_abnormal_bone_marrow | 2.03982205 |
| 23 | MP0000716_abnormal_immune_system | 1.91437759 |
| 24 | MP0008260_abnormal_autophagy | 1.89954121 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.85640485 |
| 26 | MP0001873_stomach_inflammation | 1.85306135 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.84483047 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.81072169 |
| 29 | MP0004510_myositis | 1.79771261 |
| 30 | MP0010368_abnormal_lymphatic_system | 1.78633062 |
| 31 | MP0009278_abnormal_bone_marrow | 1.77957938 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.77422115 |
| 33 | MP0005451_abnormal_body_composition | 1.77038434 |
| 34 | MP0004947_skin_inflammation | 1.76723869 |
| 35 | MP0003566_abnormal_cell_adhesion | 1.76081004 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.75792430 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.74220930 |
| 38 | MP0002006_tumorigenesis | 1.73917429 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.72231603 |
| 40 | MP0006082_CNS_inflammation | 1.71351569 |
| 41 | MP0001879_abnormal_lymphatic_vessel | 1.71298052 |
| 42 | MP0002722_abnormal_immune_system | 1.69407521 |
| 43 | MP0001853_heart_inflammation | 1.66094513 |
| 44 | MP0002933_joint_inflammation | 1.65098433 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.63767952 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.62063108 |
| 47 | MP0002429_abnormal_blood_cell | 1.59776483 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.52972948 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.52195884 |
| 50 | MP0003828_pulmonary_edema | 1.50649137 |
| 51 | MP0003279_aneurysm | 1.50312024 |
| 52 | MP0001958_emphysema | 1.48742632 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.46674806 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.46440349 |
| 55 | MP0003448_altered_tumor_morphology | 1.46043024 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.45824339 |
| 57 | MP0000858_altered_metastatic_potential | 1.40080352 |
| 58 | MP0005023_abnormal_wound_healing | 1.39168333 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.38957984 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.37126391 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.37126391 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.36928144 |
| 63 | MP0004381_abnormal_hair_follicle | 1.34041448 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.29920721 |
| 65 | MP0005058_abnormal_lysosome_morphology | 1.29362111 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 1.23251774 |
| 67 | MP0003091_abnormal_cell_migration | 1.23203373 |
| 68 | MP0000343_altered_response_to | 1.23046563 |
| 69 | MP0000767_abnormal_smooth_muscle | 1.19748213 |
| 70 | MP0003866_abnormal_defecation | 1.18125844 |
| 71 | MP0002132_abnormal_respiratory_system | 1.15720831 |
| 72 | MP0000249_abnormal_blood_vessel | 1.13201010 |
| 73 | MP0008469_abnormal_protein_level | 1.11730307 |
| 74 | MP0005076_abnormal_cell_differentiation | 1.10612665 |
| 75 | MP0008438_abnormal_cutaneous_collagen | 1.07253269 |
| 76 | MP0006054_spinal_hemorrhage | 1.05174846 |
| 77 | MP0001851_eye_inflammation | 1.03078686 |
| 78 | MP0003045_fibrosis | 1.02294051 |
| 79 | MP0002998_abnormal_bone_remodeling | 1.01375910 |
| 80 | MP0009764_decreased_sensitivity_to | 0.93538853 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.85238862 |
| 82 | MP0001663_abnormal_digestive_system | 0.85085102 |
| 83 | MP0000490_abnormal_crypts_of | 0.84534828 |
| 84 | MP0003690_abnormal_glial_cell | 0.83126483 |
| 85 | MP0005166_decreased_susceptibility_to | 0.82297980 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.77983899 |
| 87 | MP0008004_abnormal_stomach_pH | 0.77914674 |
| 88 | MP0000604_amyloidosis | 0.77805763 |
| 89 | MP0000733_abnormal_muscle_development | 0.77191790 |
| 90 | MP0008961_abnormal_basal_metabolism | 0.75993905 |
| 91 | MP0005310_abnormal_salivary_gland | 0.75877187 |
| 92 | MP0009763_increased_sensitivity_to | 0.75475185 |
| 93 | MP0009840_abnormal_foam_cell | 0.74683056 |
| 94 | MP0003075_altered_response_to | 0.74207594 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.74077531 |
| 96 | MP0005390_skeleton_phenotype | 0.73047554 |
| 97 | MP0002128_abnormal_blood_circulation | 0.72099537 |
| 98 | MP0004883_abnormal_blood_vessel | 0.70809698 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.70682365 |
| 100 | MP0001986_abnormal_taste_sensitivity | 0.67621849 |
| 101 | MP0005164_abnormal_response_to | 0.66234161 |
| 102 | MP0002925_abnormal_cardiovascular_devel | 0.64928333 |
| 103 | MP0002168_other_aberrant_phenotype | 0.64881141 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.64598595 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.64432013 |
| 106 | MP0004185_abnormal_adipocyte_glucose | 0.64429868 |
| 107 | MP0010630_abnormal_cardiac_muscle | 0.63909898 |
| 108 | MP0000015_abnormal_ear_pigmentation | 0.63558320 |
| 109 | MP0000609_abnormal_liver_physiology | 0.63414794 |
| 110 | MP0003806_abnormal_nucleotide_metabolis | 0.63094386 |
| 111 | MP0002332_abnormal_exercise_endurance | 0.62727555 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.62654304 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.61877772 |
| 114 | MP0001614_abnormal_blood_vessel | 0.61319210 |
| 115 | MP0008874_decreased_physiological_sensi | 0.61147946 |
| 116 | MP0004084_abnormal_cardiac_muscle | 0.59831051 |
| 117 | MP0003795_abnormal_bone_structure | 0.59441169 |
| 118 | MP0002009_preneoplasia | 0.58505555 |
| 119 | MP0004130_abnormal_muscle_cell | 0.56594306 |
| 120 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55679101 |
| 121 | MP0005388_respiratory_system_phenotype | 0.53232740 |
| 122 | MP0002133_abnormal_respiratory_system | 0.53232740 |
| 123 | MP0005319_abnormal_enzyme/_coenzyme | 0.50576436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spontaneous hematomas (HP:0007420) | 4.74102850 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.56971383 |
| 3 | Abnormality of the nasal mucosa (HP:0000433) | 4.48893942 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.32422098 |
| 5 | Hematochezia (HP:0002573) | 3.95927043 |
| 6 | Nasal polyposis (HP:0100582) | 3.83433327 |
| 7 | T lymphocytopenia (HP:0005403) | 3.79077961 |
| 8 | Recurrent bronchitis (HP:0002837) | 3.70486273 |
| 9 | Abnormality of T cell number (HP:0011839) | 3.66049810 |
| 10 | Pustule (HP:0200039) | 3.62839050 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.56899408 |
| 12 | Recurrent viral infections (HP:0004429) | 3.54121734 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.50244708 |
| 14 | Myositis (HP:0100614) | 3.46219715 |
| 15 | Chronic otitis media (HP:0000389) | 3.42311700 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 3.41785671 |
| 17 | Interstitial pulmonary disease (HP:0006530) | 3.37325807 |
| 18 | Urticaria (HP:0001025) | 3.32634799 |
| 19 | Cellulitis (HP:0100658) | 3.32374780 |
| 20 | IgM deficiency (HP:0002850) | 3.29871646 |
| 21 | Keratoconjunctivitis (HP:0001096) | 3.28114281 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.19979930 |
| 23 | Agammaglobulinemia (HP:0004432) | 3.10014344 |
| 24 | Inflammation of the large intestine (HP:0002037) | 3.09842584 |
| 25 | Colitis (HP:0002583) | 3.03389946 |
| 26 | Gastrointestinal inflammation (HP:0004386) | 2.97321057 |
| 27 | Papilloma (HP:0012740) | 2.96929663 |
| 28 | Verrucae (HP:0200043) | 2.96929663 |
| 29 | Cerebral aneurysm (HP:0004944) | 2.96352605 |
| 30 | Meningitis (HP:0001287) | 2.96253630 |
| 31 | Polycythemia (HP:0001901) | 2.92248767 |
| 32 | Stomatitis (HP:0010280) | 2.89513975 |
| 33 | Episodic fever (HP:0001954) | 2.87770423 |
| 34 | Abnormality of T cells (HP:0002843) | 2.85285931 |
| 35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.83093547 |
| 36 | Hypochromic anemia (HP:0001931) | 2.82854175 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 2.78019801 |
| 38 | Increased IgM level (HP:0003496) | 2.77650974 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 2.76716091 |
| 40 | Peritonitis (HP:0002586) | 2.74647095 |
| 41 | Aortic aneurysm (HP:0004942) | 2.69382890 |
| 42 | Hypochromic microcytic anemia (HP:0004840) | 2.67203633 |
| 43 | Orchitis (HP:0100796) | 2.66715414 |
| 44 | Prolonged bleeding time (HP:0003010) | 2.66650369 |
| 45 | Panhypogammaglobulinemia (HP:0003139) | 2.66322218 |
| 46 | Amyloidosis (HP:0011034) | 2.65875505 |
| 47 | Abnormality of macrophages (HP:0004311) | 2.65217267 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.63196637 |
| 49 | Anorexia (HP:0002039) | 2.63017541 |
| 50 | Obstructive lung disease (HP:0006536) | 2.60626737 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60626737 |
| 52 | Recurrent skin infections (HP:0001581) | 2.56823111 |
| 53 | Vasculitis (HP:0002633) | 2.54200261 |
| 54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.54007423 |
| 55 | Recurrent cutaneous fungal infections (HP:0011370) | 2.54007423 |
| 56 | Petechiae (HP:0000967) | 2.51799119 |
| 57 | Emphysema (HP:0002097) | 2.51749071 |
| 58 | Gingivitis (HP:0000230) | 2.48059670 |
| 59 | Abnormality of the fingertips (HP:0001211) | 2.47314184 |
| 60 | Hemoptysis (HP:0002105) | 2.47313061 |
| 61 | Lymphopenia (HP:0001888) | 2.44354349 |
| 62 | Arterial thrombosis (HP:0004420) | 2.44228384 |
| 63 | Leukocytosis (HP:0001974) | 2.40107517 |
| 64 | Hypergammaglobulinemia (HP:0010702) | 2.37840668 |
| 65 | Epistaxis (HP:0000421) | 2.37767663 |
| 66 | Increased density of long bones (HP:0006392) | 2.37478121 |
| 67 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.36420081 |
| 68 | Gastrointestinal stroma tumor (HP:0100723) | 2.35885205 |
| 69 | Periodontitis (HP:0000704) | 2.34862918 |
| 70 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.34321622 |
| 71 | Pulmonary embolism (HP:0002204) | 2.33163052 |
| 72 | Osteolytic defects of the hand bones (HP:0009699) | 2.32073360 |
| 73 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.32073360 |
| 74 | Combined immunodeficiency (HP:0005387) | 2.31307323 |
| 75 | Pulmonary infiltrates (HP:0002113) | 2.29868079 |
| 76 | Osteomyelitis (HP:0002754) | 2.29768080 |
| 77 | Sepsis (HP:0100806) | 2.27275800 |
| 78 | Abnormal platelet volume (HP:0011876) | 2.27133380 |
| 79 | Bronchitis (HP:0012387) | 2.26963607 |
| 80 | Eosinophilia (HP:0001880) | 2.26600036 |
| 81 | Optic neuritis (HP:0100653) | 2.26035257 |
| 82 | Retrobulbar optic neuritis (HP:0100654) | 2.26035257 |
| 83 | Abnormality of the pleura (HP:0002103) | 2.23483997 |
| 84 | Thyroiditis (HP:0100646) | 2.22050814 |
| 85 | Spondylolisthesis (HP:0003302) | 2.20874743 |
| 86 | Chronic sinusitis (HP:0011109) | 2.20315134 |
| 87 | Glomerulopathy (HP:0100820) | 2.19213842 |
| 88 | Gangrene (HP:0100758) | 2.18742187 |
| 89 | Recurrent sinusitis (HP:0011108) | 2.17256906 |
| 90 | Myocardial infarction (HP:0001658) | 2.17173137 |
| 91 | Severe combined immunodeficiency (HP:0004430) | 2.15568548 |
| 92 | Increased IgE level (HP:0003212) | 2.15335892 |
| 93 | Restrictive lung disease (HP:0002091) | 2.15219447 |
| 94 | Aortic dissection (HP:0002647) | 2.14860345 |
| 95 | Abnormality of the peritoneum (HP:0002585) | 2.14298947 |
| 96 | Esophageal varix (HP:0002040) | 2.14091773 |
| 97 | Increased serum ferritin (HP:0003281) | 2.12543684 |
| 98 | Vacuolated lymphocytes (HP:0001922) | 2.11810565 |
| 99 | Chest pain (HP:0100749) | 2.09177722 |
| 100 | Purpura (HP:0000979) | 2.09062366 |
| 101 | Autoimmune hemolytic anemia (HP:0001890) | 2.07494912 |
| 102 | Slow saccadic eye movements (HP:0000514) | 2.07436598 |
| 103 | Gastrointestinal infarctions (HP:0005244) | 2.06319885 |
| 104 | Viral hepatitis (HP:0006562) | 2.05457005 |
| 105 | Skin ulcer (HP:0200042) | 2.05080654 |
| 106 | Microcytic anemia (HP:0001935) | 2.05003665 |
| 107 | B lymphocytopenia (HP:0010976) | 2.04668562 |
| 108 | Abnormality of B cell number (HP:0010975) | 2.04668562 |
| 109 | Abnormality of the endocardium (HP:0004306) | 2.02599321 |
| 110 | Abnormality of eosinophils (HP:0001879) | 2.02554619 |
| 111 | Abnormality of T cell physiology (HP:0011840) | 2.01676117 |
| 112 | Hepatosplenomegaly (HP:0001433) | 2.01640021 |
| 113 | Mitral stenosis (HP:0001718) | 2.01406429 |
| 114 | Premature loss of primary teeth (HP:0006323) | 2.00836158 |
| 115 | Gingival bleeding (HP:0000225) | 2.00209871 |
| 116 | Thrombocytosis (HP:0001894) | 1.95793381 |
| 117 | Keratitis (HP:0000491) | 1.93934197 |
| 118 | Granulocytopenia (HP:0001913) | 1.93577727 |
| 119 | IgG deficiency (HP:0004315) | 1.93001996 |
| 120 | Subacute progressive viral hepatitis (HP:0006572) | 1.92834686 |
| 121 | Abnormality of the pericardium (HP:0001697) | 1.92333452 |
| 122 | Loss of speech (HP:0002371) | 1.92111349 |
| 123 | Abnormal platelet function (HP:0011869) | 1.92109994 |
| 124 | Impaired platelet aggregation (HP:0003540) | 1.92109994 |
| 125 | Dysostosis multiplex (HP:0000943) | 1.91911578 |
| 126 | Encephalitis (HP:0002383) | 1.91780999 |
| 127 | IgA deficiency (HP:0002720) | 1.90613730 |
| 128 | Joint swelling (HP:0001386) | 1.90607509 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 1.89157175 |
| 130 | Acne (HP:0001061) | 1.88979950 |
| 131 | Increased mean platelet volume (HP:0011877) | 1.88049959 |
| 132 | Acute hepatic failure (HP:0006554) | 1.87993461 |
| 133 | Keratoconjunctivitis sicca (HP:0001097) | 1.87373825 |
| 134 | Vertigo (HP:0002321) | 1.82371339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.94435509 |
| 2 | STK10 | 2.95405103 |
| 3 | TXK | 2.76898382 |
| 4 | PRPF4B | 2.76745189 |
| 5 | ERN1 | 2.54349366 |
| 6 | TGFBR2 | 2.52475592 |
| 7 | TRIB3 | 2.46053817 |
| 8 | TYK2 | 2.42452469 |
| 9 | GRK6 | 2.39054319 |
| 10 | ZAP70 | 2.25695378 |
| 11 | MAP3K10 | 2.20584684 |
| 12 | ITK | 2.16934958 |
| 13 | FGFR4 | 2.10175768 |
| 14 | TNK2 | 2.09738552 |
| 15 | JAK3 | 2.09164853 |
| 16 | BLK | 2.05614133 |
| 17 | CSK | 2.02256905 |
| 18 | LRRK2 | 2.01309376 |
| 19 | JAK1 | 1.98260895 |
| 20 | TTN | 1.98079221 |
| 21 | KDR | 1.96838907 |
| 22 | PKN2 | 1.93144800 |
| 23 | TIE1 | 1.88928765 |
| 24 | EPHB1 | 1.69495442 |
| 25 | TAOK1 | 1.67511838 |
| 26 | TBK1 | 1.65813552 |
| 27 | MAP3K14 | 1.63507436 |
| 28 | BTK | 1.54952470 |
| 29 | SIK3 | 1.53134826 |
| 30 | FGFR3 | 1.51849481 |
| 31 | IKBKE | 1.50839385 |
| 32 | MAP2K3 | 1.48929503 |
| 33 | MAP3K11 | 1.48919663 |
| 34 | HCK | 1.42508691 |
| 35 | TEC | 1.42468111 |
| 36 | MARK3 | 1.37652525 |
| 37 | EEF2K | 1.36728628 |
| 38 | KIT | 1.29871795 |
| 39 | LCK | 1.28037776 |
| 40 | MAP3K1 | 1.26151918 |
| 41 | IRAK4 | 1.25402641 |
| 42 | SYK | 1.18596129 |
| 43 | MAP3K13 | 1.17916788 |
| 44 | KSR2 | 1.16637104 |
| 45 | CDK12 | 1.14741716 |
| 46 | RIPK1 | 1.14324883 |
| 47 | SMG1 | 1.10776323 |
| 48 | PTK6 | 1.10760273 |
| 49 | CSF1R | 1.09948183 |
| 50 | PIM1 | 1.09014080 |
| 51 | RPS6KA4 | 1.08609984 |
| 52 | MST4 | 1.08465916 |
| 53 | NLK | 1.06543545 |
| 54 | IKBKB | 1.06336491 |
| 55 | TAOK2 | 1.03929414 |
| 56 | IRAK3 | 1.03870165 |
| 57 | YES1 | 1.01111377 |
| 58 | MARK2 | 0.97947869 |
| 59 | PRKCH | 0.97787262 |
| 60 | CLK1 | 0.93907874 |
| 61 | IRAK1 | 0.91831283 |
| 62 | FES | 0.91106032 |
| 63 | BMPR2 | 0.87841192 |
| 64 | CAMK1D | 0.86712742 |
| 65 | SIK2 | 0.84741873 |
| 66 | JAK2 | 0.81678203 |
| 67 | DMPK | 0.80825436 |
| 68 | MATK | 0.80767931 |
| 69 | TGFBR1 | 0.78944856 |
| 70 | EPHA3 | 0.76962987 |
| 71 | MAP3K6 | 0.76643776 |
| 72 | PDPK1 | 0.76468935 |
| 73 | HIPK2 | 0.76456042 |
| 74 | PAK4 | 0.76034379 |
| 75 | CHUK | 0.75501247 |
| 76 | SIK1 | 0.73528322 |
| 77 | PRKCQ | 0.73142568 |
| 78 | IRAK2 | 0.72574000 |
| 79 | LYN | 0.72326783 |
| 80 | TRPM7 | 0.70477293 |
| 81 | CDC42BPA | 0.68496509 |
| 82 | NEK9 | 0.67574903 |
| 83 | MAP3K7 | 0.67419240 |
| 84 | TAOK3 | 0.66374658 |
| 85 | RIPK4 | 0.65787589 |
| 86 | PDGFRB | 0.64514029 |
| 87 | PTK2B | 0.64368996 |
| 88 | MYLK | 0.63031316 |
| 89 | MELK | 0.57887228 |
| 90 | MAP3K3 | 0.57662069 |
| 91 | CAMK1G | 0.57167556 |
| 92 | MAP3K2 | 0.56368394 |
| 93 | PIK3CG | 0.56044850 |
| 94 | CDK4 | 0.55901331 |
| 95 | CDK9 | 0.55000255 |
| 96 | CDK6 | 0.48995503 |
| 97 | MAP3K5 | 0.48966930 |
| 98 | PRKD2 | 0.48868671 |
| 99 | STK38 | 0.48502335 |
| 100 | STK24 | 0.48346825 |
| 101 | MAPK12 | 0.48135068 |
| 102 | MOS | 0.47884745 |
| 103 | BMX | 0.47461662 |
| 104 | FGR | 0.47016400 |
| 105 | EGFR | 0.46753797 |
| 106 | STK4 | 0.46188740 |
| 107 | PDGFRA | 0.45361060 |
| 108 | GRK7 | 0.44899467 |
| 109 | PRKD1 | 0.44899452 |
| 110 | SGK3 | 0.44514531 |
| 111 | GRK1 | 0.44189385 |
| 112 | ILK | 0.43430214 |
| 113 | RAF1 | 0.42392513 |
| 114 | RPS6KA6 | 0.41941414 |
| 115 | MAP3K8 | 0.41540109 |
| 116 | DYRK1B | 0.41478787 |
| 117 | PDK1 | 0.41443254 |
| 118 | CDK19 | 0.41327903 |
| 119 | RET | 0.40936192 |
| 120 | FLT3 | 0.40906841 |
| 121 | STK11 | 0.39964597 |
| 122 | CAMKK1 | 0.38083003 |
| 123 | INSR | 0.38040337 |
| 124 | MAP2K6 | 0.37962714 |
| 125 | ABL1 | 0.37815725 |
| 126 | PRKG2 | 0.37412396 |
| 127 | FYN | 0.37118106 |
| 128 | MAPK11 | 0.36239585 |
| 129 | MAPKAPK2 | 0.35985925 |
| 130 | TESK2 | 0.35653165 |
| 131 | MAPK7 | 0.34677483 |
| 132 | IGF1R | 0.34189857 |
| 133 | ALK | 0.34010403 |
| 134 | RPS6KL1 | 0.33116433 |
| 135 | RPS6KC1 | 0.33116433 |
| 136 | MAP2K2 | 0.30111983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.55815295 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.66021092 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.60594941 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.54991839 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.35296900 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.28713597 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27903649 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.25100212 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.19277882 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.17855690 |
| 11 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.15825677 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.15395183 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.14829407 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.99821974 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.89215981 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.76994293 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.76034895 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.74076850 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66807865 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.64075231 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.52314971 |
| 22 | Platelet activation_Homo sapiens_hsa04611 | 1.50800583 |
| 23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.49241171 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.47208939 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.44361392 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42593712 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.40746909 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.40227921 |
| 29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37211599 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37011140 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36745168 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.32451219 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30983615 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.29702313 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28097597 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27257360 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.26734654 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.26582981 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.24526100 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21897068 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21453683 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19854356 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.19498338 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.17490596 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17241006 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10522161 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.09563955 |
| 48 | Focal adhesion_Homo sapiens_hsa04510 | 1.08508180 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.04635981 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.03147443 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.02633076 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01830545 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99780474 |
| 54 | Adherens junction_Homo sapiens_hsa04520 | 0.97389436 |
| 55 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.97353306 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96523500 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94787570 |
| 58 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.88943778 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 0.87815443 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.87745834 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.84774453 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84514561 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83444712 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.82684876 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80933528 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80729062 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80669792 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.80192668 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78088978 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.76700079 |
| 71 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73299138 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72989976 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72705432 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72144363 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.70666573 |
| 76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69684998 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69337675 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67350099 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66105496 |
| 80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65677138 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64546682 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61089953 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60715030 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59916934 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59362386 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58305579 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57070467 |
| 88 | Asthma_Homo sapiens_hsa05310 | 0.55089848 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54206231 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52952979 |
| 91 | Pathways in cancer_Homo sapiens_hsa05200 | 0.52251398 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51943357 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50541851 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48555088 |
| 95 | Prostate cancer_Homo sapiens_hsa05215 | 0.48469918 |
| 96 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48047931 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47672152 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47081624 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43891384 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43734548 |
| 101 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43724477 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43687332 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43261366 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42615132 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.41572700 |
| 106 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40650385 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40107080 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39981333 |
| 109 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.38558214 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38021412 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.37152290 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36544514 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35646146 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32948241 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32861849 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30787513 |

